FDA Inspection 1073522 — Lupin Limited
The FDA completed an inspection of Lupin Limited on Dec 4, 2018 in Mandideep. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Dec 4, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mandideep (India)